Month: April 2020

Lassila & Tikanoja OyjSijoittajauutinen14.4.2020 klo 15.00Lassila & Tikanoja Oyj julkaisee osavuosikatsauksen tammi-maaliskuulta keskiviikkona 28.4.2020 klo 8.00. Tiedote on julkistuksen jälkeen luettavissa yhtiön internetsivuilla www.lt.fi.Lassila & Tikanoja järjestää webcast-lähetyksen analyytikoille, institutionaalisille sijoittajille ja medialle 28.4. klo 9.00. Esitysmateriaali julkaistaan yhtiön internetsivuilla.Tilaisuus on suomenkielinen. Tilaisuutta isännöivät yhtiön toimitusjohtaja Eero Hautaniemi sekä talousjohtaja Valtteri Palin.Webcast-lähetykseen voi osallistua tästä linkistä: https://webcast.reloadmedia.fi/quarterlyreport/?q=280420Osallistujia pyydetään rekisteröitymään linkin kautta hieman ennen lähetyksen alkua.Lassila & Tikanoja järjestää englanninkielisiä puhelinkonferensseja erikseen sovittavina...

FORT WAYNE, Ind., April 14, 2020 (GLOBE NEWSWIRE) — Franklin Electric Co., Inc. (NASDAQ: FELE) will release its first quarter 2020 earnings at 8:00 am ET on Tuesday, April 28, 2020.  A conference call to review earnings and other developments in the business will commence at 9:00 am ET.  The first quarter 2020 earnings call will be available via a live webcast.  The webcast will be available in a listen only mode by going to:https://edge.media-server.com/mmc/p/thsfw4zoIf you intend to ask questions during the call, please dial in using 877.643.7158 for domestic calls and 914.495.8565 for international calls.  The conference ID is: 5472646.A replay of the conference call will be available Tuesday, April 28, 2020 at 12:00 noon ET through noon ET on Tuesday, May 5, 2020, by dialing 855.859.2056 for domestic calls and 404.537.3406 for...

Nunzia Pharmaceutical Launches its Breakthrough NUNZIA Nutraceutical and Pharma Treatment for Autism Spectrum and Other Anxiety DisordersSAN CLEMENTE, CA, April 14, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Nunzia Pharmaceutical Corporation (OTC MKTS: NUNZ), an emerging leader in innovative pharmaceutical and nutraceutical based therapies for the treatment of behavioral anxiety symptoms of Autistic Spectrum of Disorders (ASD’s) and other anxiety disorders, is pleased to announce the launch of its landmark NUNZIA nutraceuticals available direct to consumers through the Company’s website, www.nunziapharma.com. NUNZIA provides a highly effective and targeted supplement for a rapidly growing autism market. In 2000, less than 1 in 150 American children were affected by autism, a prevalence that is now 1 in 45- there are 1.4 million children...

SECURITIES REPURCHASING PROGRAMME(Decided by the annual shareholders’ meeting of 17 May 2019)Disclosure of trading in own sharesPeriod from 3 to 9 April 2020Issuer : COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELINLEI : 549300SOSI58J6VIW052Types of securities: ordinary shares (ISIN : FR 0000121261)Full details of the programme disclosed on 7 January 2020Purchases effected during the period:(*) Shares purchased through a derivative instrument are included. Are excluded transactions carried out in connection with the execution of a contract to increase share market liquidity.AttachmentModèle EN déclaration hebdo 14.04.2020

Company Announcement No. 828Pursuant to section 30 of the Danish Capital Markets Act it is hereby announced that The Capital Group Companies, Inc. has informed DSV Panalpina A/S that Capital Group has reduced its holding of shares and other financial instruments with similar economic effect in DSV Panalpina A/S to 11,662,475 shares, corresponding to 4.96% of the entire share capital and voting rights.Any questions may be addressed to Executive Vice President, Investor Relations, Flemming Ole Nielsen, tel. +45 43 20 33 92.Yours sincerely,DSV Panalpina A/SAttachment828 – Announcement (14.04.2020) – Major shareholder announcement